We investigated the regulation of Sox9, a transcription factor known to pla
y a role in chondrogenesis, by bone morphogenetic protein-2 (BMP-2) and hed
gehog proteins in order to better understand their signaling function in en
dochondral bone formation. The mesenchymal progenitor cell line C3H10T1/2 w
as stimulated with BMP-2. Sox9 expression levels were measured by quantitat
ive reverse transcriptase-polymerase chain reaction and Northern analysis.
We found that Sox9 was up-regulated by BMP-2 in a dose-dependent manner. Th
e expression of Col2a1, a downstream response gene of Sox9, was also signif
icantly increased upon BMP-2 addition, We also monitored Sox9 expression af
ter the addition of BMP-2 to osteosarcoma cell lines; BMP-2 treatment incre
ased Sox9 mRNA levels in MG63, considered to be early osteoblast-like, but
not in human osteogenic sarcoma (HOS) cells, which are thought to be more a
dvanced in the osteoblastic lineage. This response seems to be influenced b
y differences in BMP receptor expression; MG63 cells express BMP receptor I
A (BMPR-IA), whereas HOS cells express BMPR-IA and BMPR-IB. We also saw an
increase in Sox9 mRNA levels in BMP-2-treated primary human bone cells (HBC
s) derived from femoral heads. We found that in addition to BMP-2, Sonic an
d Indian hedgehog can increase Sox9 expression in C3H10T1/2 and primary HBC
s. Time course studies with C3H10T1/2 cells after BMP-2 stimulation showed
increasing expression of cartilage markers, decrease of collagen I mRNA, an
d a late induction of osteocalcin expression. Moreover, the treatment of C3
H10T1/2 cells with Sox9 antisense oligonucleotides revealed that Sox9 is a
downstream mediator of BMP-2 affecting the expression of chondrocyte and os
teoblast marker genes. Our data show that Sox9 is an important downstream m
ediator of the BMP-2 and hedgehog signaling pathways in osteogenic cells.